Targeting of interleukin (IL)-17A inhibits PDL1 expression in tumor cells and induces anticancer immunity in an estrogen receptor-negative murine model of breast cancer
Yunfeng Ma(China Pharmaceutical University), Jiru Xu(Xi'an Jiaotong University), Yanhong Ji(Lanzhou Veterinary Research Institute), Dongqing Li(Wuhan University), Zhuangwei Lv(Xi'an Jiaotong University), Chen Chen(Hangzhou Medical College), Min Liu(Wuhan University)
Cited by 47
Related Papers
The biology and role of CD44 in cancer progression: therapeutic implications
|Journal of Hematology & Oncology|2018|1.4k
Correction: Corrigendum: Differential developmental requirement and peripheral regulation for dermal Vγ4 and Vγ6T17 cells in health and inflammation
|Nature Communications|2016|536
Exosomal circPACRGL promotes progression of colorectal cancer via the miR-142-3p/miR-506-3p- TGF-β1 axis
|Molecular Cancer|2020|465
A genetic variation map for chicken with 2.8 million single-nucleotide polymorphisms
|Nature|2004|456
The crystal structure of Cpf1 in complex with CRISPR RNA
|Nature|2016|421